HER2 In Breast Cancer: Testing Guidelines and New Treatment Approaches

Treatment Options for HER2+ Breast Cancer: A Comprehensive GuideПодробнее

Personalized treatment of advanced HER2-negative gastric or gastroesophageal junction cancerПодробнее

Lung Cancer New Treatment 2023Подробнее

Updates in Systemic Therapy for Breast Cancer 2/8/23Подробнее

Are You Prepared for the New Wave of ADCs in NSCLC? Targeting HER2, HER3, TROP2, and OthersПодробнее

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment ArsenalПодробнее

Adjuvant Therapy | 2023 Best of Breast ConferenceПодробнее

HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review ConferenceПодробнее

What's New in Screening and Treatment for Lobular Breast CancerПодробнее

Testing, Treating, and Targeting Triple Negative Breast Cancer | 2023 West Oncology ConferenceПодробнее

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

HER2 Testing in Breast Cancer: Improving IHC PerformanceПодробнее

New Perspectives on the Full Spectrum of HER2 Expression in Breast CancerПодробнее

2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment ApproachesПодробнее

Guideline Updates for Extended Endocrine Therapy Decision-Making in HR+, Early-Stage Breast CancerПодробнее

Breast Cancer Management in North Carolina: Updates for 2021 - Y. Abdou - 20210623Подробнее

Medical update: HER2-Positive and triple-positive metastatic breast cancerПодробнее

Dr Praveen Paliwal | New Treatment approaches in HER2 +ve Metastatic Breast CancerПодробнее

WEBINAR: New Treatment Options for Metastatic Breast CancerПодробнее

Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid TumorsПодробнее